首页> 外国专利> Murine monoclonal antibody from hybridoma Lym-1 - used in diagnosis and therapy of B-cell derived human lymphomas and leukemias

Murine monoclonal antibody from hybridoma Lym-1 - used in diagnosis and therapy of B-cell derived human lymphomas and leukemias

机译:杂交瘤Lym-1的鼠单克隆抗体-用于诊断和治疗B细胞源性人淋巴瘤和白血病

摘要

A murine monoclonal antibody of class IgG2a has the properties: (a) it reacts with all normal human peripheral blood and lymph node B cells but not with normal peripheral blood or lymph node T cells, null cells, macrophages, platelets, red blood cells or granulocytes, (b) exhibits reactivity with specified human B-cell lines, (c) reacts with specified human B-cell lymphomas and B-cell chronic lymphocytic leukemias, (d) does not react with human lymphoma or leukemia T-cell tumours, (e) does not react with normal human tissues other than specified B cells of peripheral blood and lymph node and (f) does not react with specified human solid tumour cell lines. The monoclonal antibodies are produced by hybridoma Lym-1 (ATCC HB8612) produced by fusion of NS-1 mouse myeloma cells with Balb/c mouse splenocytes primed with Raji human lymphoma nuclei.
机译:鼠类IgG2a类单克隆抗体具有以下特性:(a)它与所有正常人外周血和淋巴结B细胞反应,但不与正常外周血或淋巴结T细胞,空细胞,巨噬细胞,血小板,红细胞或(b)与特定的人类B细胞系表现出反应性;(c)与特定的人类B细胞淋巴瘤和B细胞慢性淋巴细胞性白血病反应;(d)不与人类淋巴瘤或白血病T细胞肿瘤反应; (e)除外周血和淋巴结的特定B细胞外,不与正常人体组织反应;(f)与特定人实体瘤细胞系不反应。单克隆抗体是通过杂交瘤Lym-1(ATCC HB8612)产生的,该杂交瘤是通过将NS-1小鼠骨髓瘤细胞与用Raji人淋巴瘤细胞核引发的Balb / c小鼠脾细胞融合而产生的。

著录项

  • 公开/公告号PT86333A

    专利类型

  • 公开/公告日1988-01-01

    原文格式PDF

  • 申请/专利权人 NORTHWESTERN UNIVERSITY;

    申请/专利号PT19870086333

  • 发明设计人

    申请日1987-12-10

  • 分类号C12N15/00;

  • 国家 PT

  • 入库时间 2022-08-22 06:58:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号